United States · FDA National Drug Code directory
BRIXADI
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 58284-296_4e1985eb-1302-42e0-ac79-10b0a492966a
- Product NDC
- 58284-296
- Form
- INJECTION
- Composition / generic term
- BUPRENORPHINE
- Labeler
- Braeburn Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20230606
- Source listing expiry
- 20271231
Source-listed ingredients
- BUPRENORPHINE — 96 mg/.27mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE, GLASS in 1 CARTON (58284-296-01) / .27 mL in 1 SYRINGE, GLASS · 58284-296-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →